Regeneron and Sanofi bust into new I-O market with FDA nod for Libtayo in basal cell carcinoma arlene.weintraub […]
Month: February 2021
FDA panel doesn’t buy Merck’s biomarker for fast Keytruda nod in TNBC, spelling trouble for other I-O meds […]
A Cleveland Clinic-led team of researchers has developed a personalized genomic medicine platform that will help advance accelerate […]
Mark Redfern receives an NIH award to establish a new program in the Human Factors of Aging to […]
The UK government wasted hundreds of millions of pounds of taxpayers’ money on poor quality and unusable personal […]
Esketamine nasal spray—sold under the name Spravato—has been approved by the European Commission as a short term treatment […]
I want to set the record straight about some serious misinformation surrounding covid-19 death certification and mortality statistics. […]
Trial is sponsored by the US National Institute of Allergy and Infectious Diseases (NIAID)
The CF STORM trial will seek to address how the treatment burden for people with CF can be […]
First immunotherapy indicated for certain BCC patients